Idalopirdine – A Small Molecule Antagonist of 5-Ht6 With Therapeutic Potential Against Obesity

Metabolic Brain Disease - United States
doi 10.1007/s11011-015-9736-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Idalopirdine, a Selective 5-Ht6 Receptor Antagonist, Reduces Food Intake and Body Weight in a Model of Excessive Eating

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2018English

Therapeutic Potential of a Novel Small Molecule in Modifying Lumbar Disc Degeneration

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Co-Administration of 5-Ht6 Receptor Antagonists With Clozapine, Risperidone, and a 5-Ht2a Receptor Antagonist: Effects on Prepulse Inhibition in Rats

Psychopharmacology
Pharmacology
2013English

Small Molecule Modulators of Keap1-Nrf2-Are Pathway as Potential Preventive and Therapeutic Agents

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2012English

Adipose ABCG1: A Potential Therapeutic Target in Obesity?

Adipocyte
HistologyCell Biology
2015English

Assessment of siRNA as a Therapeutic Molecule in Transient Receptor Potential Channel 5 Gene Silencing: A Computational Approach

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2018English

E-Therapy as a Therapeutic Strategy Against Adolescent Obesity

ARC Journal of Pediatrics
2015English

Therapeutic Potential of Herbs Against Diabetes

Pure and Applied Biology
2013English

Therapeutic and Prophylactic Potential of Small Interfering RNAs Against Severe Acute Respiratory Syndrome

BioDrugs
MedicineBiotechnologyPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy